ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Favipiravir API Market Research Report 2026
Published Date: 2026-01-21
|
Report Code: QYRE-Auto-3X20019
Home | Market Reports
Global Favipiravir API Market Outlook In Depth Analysis Forecast to 2031
BUY CHAPTERS

Global Favipiravir API Market Research Report 2026

Code: QYRE-Auto-3X20019
Report
2026-01-21
Pages:144
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Chunghwa Chemical Synthesis & Biotech
Tagoor Laboratories
Biophore
Lee Pharma
Forewin Pharma
Senova Technology
Zhejiang Hengkang Pharmaceutical
Maithili Life Sciences
Hangzhou HETA Pharm & Chem
Aurore Life Sciences
Bajaj Healthcare
TODACO

Favipiravir API Market Size

The global Favipiravir API market was valued at US$ 1661 million in 2025 and is anticipated to reach US$ 2250 million by 2032, at a CAGR of 4.5% from 2026 to 2032.

Favipiravir API Market

Favipiravir API Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Favipiravir API competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Favipiravir API is a broad-spectrum antiviral drug with the chemical name 6-fluoro-3-hydroxy-pyrazine-2-carboxamide. It acts on the viral RNA-dependent RNA polymerase, accelerating virus clearance to alleviate viral infections. As an Active Pharmaceutical Ingredient (API) in the pharmaceutical industry, Favipiravir is used to treat diseases caused by various RNA viruses.
The North American market for Favipiravir API is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Favipiravir API is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Favipiravir API include Chunghwa Chemical Synthesis & Biotech, TODACO, Tagoor Laboratories, Biophore, Lee Pharma, Forewin Pharma, Senova Technology, Zhejiang Hengkang Pharmaceutical, Maithili Life Sciences, Hangzhou HETA Pharm & Chem, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Favipiravir API market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Favipiravir API. The Favipiravir API market size, estimates, and forecasts are provided in terms of shipments (Tons) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Favipiravir API market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Favipiravir API manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Favipiravir API Market Report

Report Metric Details
Report Name Favipiravir API Market
Accounted market size in 2025 US$ 1661 in million
Forecasted market size in 2032 US$ 2250 million
CAGR 4.5%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Purity ≥ 98%
  • Purity < 98%
by Application
  • Pharmaceuticals
  • Scientific Research
  • Others
Production by Region
  • North America
  • Europe
  • China
  • Japan
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Chunghwa Chemical Synthesis & Biotech, TODACO, Tagoor Laboratories, Biophore, Lee Pharma, Forewin Pharma, Senova Technology, Zhejiang Hengkang Pharmaceutical, Maithili Life Sciences, Hangzhou HETA Pharm & Chem, Aurore Life Sciences, Bajaj Healthcare
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Favipiravir API manufacturers, including prices, production, value-based market shares, latest development plans, and information on mergers and acquisitions.
  • Chapter 3: Examines Favipiravir API production/output and value by region and country, providing a quantitative assessment of market size and growth potential for each region over the next six years.
  • Chapter 4: Analyzes Favipiravir API consumption at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national production.
  • Chapter 5: Analyzes market segments by Type, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 6: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 7: Profiles key players, detailing the fundamentals of major companies, including product production/output, value, price, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 8: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 9: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 10: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Favipiravir API Market growing?

Ans: The Favipiravir API Market witnessing a CAGR of 4.5% during the forecast period 2026-2032.

What is the Favipiravir API Market size in 2032?

Ans: The Favipiravir API Market size in 2032 will be US$ 2250 million.

Who are the main players in the Favipiravir API Market report?

Ans: The main players in the Favipiravir API Market are Chunghwa Chemical Synthesis & Biotech, TODACO, Tagoor Laboratories, Biophore, Lee Pharma, Forewin Pharma, Senova Technology, Zhejiang Hengkang Pharmaceutical, Maithili Life Sciences, Hangzhou HETA Pharm & Chem, Aurore Life Sciences, Bajaj Healthcare

What are the Application segmentation covered in the Favipiravir API Market report?

Ans: The Applications covered in the Favipiravir API Market report are Pharmaceuticals, Scientific Research, Others

What are the Type segmentation covered in the Favipiravir API Market report?

Ans: The Types covered in the Favipiravir API Market report are Purity ≥ 98%, Purity < 98%

1 Favipiravir API Market Overview
1.1 Product Definition
1.2 Favipiravir API by Type
1.2.1 Global Favipiravir API Market Value Growth Rate Analysis by Type: 2025 vs 2032
1.2.2 Purity ≥ 98%
1.2.3 Purity < 98%
1.3 Favipiravir API by Application
1.3.1 Global Favipiravir API Market Value Growth Rate Analysis by Application: 2025 vs 2032
1.3.2 Pharmaceuticals
1.3.3 Scientific Research
1.3.4 Others
1.4 Global Market Growth Prospects
1.4.1 Global Favipiravir API Production Value Estimates and Forecasts (2021–2032)
1.4.2 Global Favipiravir API Production Capacity Estimates and Forecasts (2021–2032)
1.4.3 Global Favipiravir API Production Estimates and Forecasts (2021–2032)
1.4.4 Global Favipiravir API Market Average Price Estimates and Forecasts (2021–2032)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Favipiravir API Production Market Share by Manufacturers (2021–2026)
2.2 Global Favipiravir API Production Value Market Share by Manufacturers (2021–2026)
2.3 Global Key Players of Favipiravir API, Industry Ranking, 2024 vs 2025
2.4 Global Favipiravir API Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.5 Global Favipiravir API Average Price by Manufacturers (2021–2026)
2.6 Global Key Manufacturers of Favipiravir API, Manufacturing Footprints and Headquarters
2.7 Global Key Manufacturers of Favipiravir API, Product Offerings and Applications
2.8 Global Key Manufacturers of Favipiravir API, Date of Entry into the Industry
2.9 Favipiravir API Market Competitive Situation and Trends
2.9.1 Favipiravir API Market Concentration Rate
2.9.2 Top 5 and Top 10 Global Favipiravir API Players Market Share by Revenue
2.10 Mergers & Acquisitions and Expansion
3 Favipiravir API Production by Region
3.1 Global Favipiravir API Production Value Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
3.2 Global Favipiravir API Production Value by Region (2021–2032)
3.2.1 Global Favipiravir API Production Value by Region (2021–2026)
3.2.2 Global Forecasted Production Value of Favipiravir API by Region (2027–2032)
3.3 Global Favipiravir API Production Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
3.4 Global Favipiravir API Production Volume by Region (2021–2032)
3.4.1 Global Favipiravir API Production by Region (2021–2026)
3.4.2 Global Forecasted Production of Favipiravir API by Region (2027–2032)
3.5 Global Favipiravir API Market Price Analysis by Region (2021–2026)
3.6 Global Favipiravir API Production, Value, and Year-over-Year Growth
3.6.1 North America Favipiravir API Production Value Estimates and Forecasts (2021–2032)
3.6.2 Europe Favipiravir API Production Value Estimates and Forecasts (2021–2032)
3.6.3 China Favipiravir API Production Value Estimates and Forecasts (2021–2032)
3.6.4 Japan Favipiravir API Production Value Estimates and Forecasts (2021–2032)
4 Favipiravir API Consumption by Region
4.1 Global Favipiravir API Consumption Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
4.2 Global Favipiravir API Consumption by Region (2021–2032)
4.2.1 Global Favipiravir API Consumption by Region (2021–2026)
4.2.2 Global Favipiravir API Forecasted Consumption by Region (2027–2032)
4.3 North America
4.3.1 North America Favipiravir API Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.3.2 North America Favipiravir API Consumption by Country (2021–2032)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Favipiravir API Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.4.2 Europe Favipiravir API Consumption by Country (2021–2032)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Favipiravir API Consumption Growth Rate by Region: 2021 vs 2025 vs 2032
4.5.2 Asia Pacific Favipiravir API Consumption by Region (2021–2032)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Favipiravir API Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.6.2 Latin America, Middle East & Africa Favipiravir API Consumption by Country (2021–2032)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Favipiravir API Production by Type (2021–2032)
5.1.1 Global Favipiravir API Production by Type (2021–2026)
5.1.2 Global Favipiravir API Production by Type (2027–2032)
5.1.3 Global Favipiravir API Production Market Share by Type (2021–2032)
5.2 Global Favipiravir API Production Value by Type (2021–2032)
5.2.1 Global Favipiravir API Production Value by Type (2021–2026)
5.2.2 Global Favipiravir API Production Value by Type (2027–2032)
5.2.3 Global Favipiravir API Production Value Market Share by Type (2021–2032)
5.3 Global Favipiravir API Price by Type (2021–2032)
6 Segment by Application
6.1 Global Favipiravir API Production by Application (2021–2032)
6.1.1 Global Favipiravir API Production by Application (2021–2026)
6.1.2 Global Favipiravir API Production by Application (2027–2032)
6.1.3 Global Favipiravir API Production Market Share by Application (2021–2032)
6.2 Global Favipiravir API Production Value by Application (2021–2032)
6.2.1 Global Favipiravir API Production Value by Application (2021–2026)
6.2.2 Global Favipiravir API Production Value by Application (2027–2032)
6.2.3 Global Favipiravir API Production Value Market Share by Application (2021–2032)
6.3 Global Favipiravir API Price by Application (2021–2032)
7 Key Companies Profiled
7.1 Chunghwa Chemical Synthesis & Biotech
7.1.1 Chunghwa Chemical Synthesis & Biotech Favipiravir API Company Information
7.1.2 Chunghwa Chemical Synthesis & Biotech Favipiravir API Product Portfolio
7.1.3 Chunghwa Chemical Synthesis & Biotech Favipiravir API Production, Value, Price, and Gross Margin (2021–2026)
7.1.4 Chunghwa Chemical Synthesis & Biotech Main Business and Markets Served
7.1.5 Chunghwa Chemical Synthesis & Biotech Recent Developments/Updates
7.2 TODACO
7.2.1 TODACO Favipiravir API Company Information
7.2.2 TODACO Favipiravir API Product Portfolio
7.2.3 TODACO Favipiravir API Production, Value, Price, and Gross Margin (2021–2026)
7.2.4 TODACO Main Business and Markets Served
7.2.5 TODACO Recent Developments/Updates
7.3 Tagoor Laboratories
7.3.1 Tagoor Laboratories Favipiravir API Company Information
7.3.2 Tagoor Laboratories Favipiravir API Product Portfolio
7.3.3 Tagoor Laboratories Favipiravir API Production, Value, Price, and Gross Margin (2021–2026)
7.3.4 Tagoor Laboratories Main Business and Markets Served
7.3.5 Tagoor Laboratories Recent Developments/Updates
7.4 Biophore
7.4.1 Biophore Favipiravir API Company Information
7.4.2 Biophore Favipiravir API Product Portfolio
7.4.3 Biophore Favipiravir API Production, Value, Price, and Gross Margin (2021–2026)
7.4.4 Biophore Main Business and Markets Served
7.4.5 Biophore Recent Developments/Updates
7.5 Lee Pharma
7.5.1 Lee Pharma Favipiravir API Company Information
7.5.2 Lee Pharma Favipiravir API Product Portfolio
7.5.3 Lee Pharma Favipiravir API Production, Value, Price, and Gross Margin (2021–2026)
7.5.4 Lee Pharma Main Business and Markets Served
7.5.5 Lee Pharma Recent Developments/Updates
7.6 Forewin Pharma
7.6.1 Forewin Pharma Favipiravir API Company Information
7.6.2 Forewin Pharma Favipiravir API Product Portfolio
7.6.3 Forewin Pharma Favipiravir API Production, Value, Price, and Gross Margin (2021–2026)
7.6.4 Forewin Pharma Main Business and Markets Served
7.6.5 Forewin Pharma Recent Developments/Updates
7.7 Senova Technology
7.7.1 Senova Technology Favipiravir API Company Information
7.7.2 Senova Technology Favipiravir API Product Portfolio
7.7.3 Senova Technology Favipiravir API Production, Value, Price, and Gross Margin (2021–2026)
7.7.4 Senova Technology Main Business and Markets Served
7.7.5 Senova Technology Recent Developments/Updates
7.8 Zhejiang Hengkang Pharmaceutical
7.8.1 Zhejiang Hengkang Pharmaceutical Favipiravir API Company Information
7.8.2 Zhejiang Hengkang Pharmaceutical Favipiravir API Product Portfolio
7.8.3 Zhejiang Hengkang Pharmaceutical Favipiravir API Production, Value, Price, and Gross Margin (2021–2026)
7.8.4 Zhejiang Hengkang Pharmaceutical Main Business and Markets Served
7.8.5 Zhejiang Hengkang Pharmaceutical Recent Developments/Updates
7.9 Maithili Life Sciences
7.9.1 Maithili Life Sciences Favipiravir API Company Information
7.9.2 Maithili Life Sciences Favipiravir API Product Portfolio
7.9.3 Maithili Life Sciences Favipiravir API Production, Value, Price, and Gross Margin (2021–2026)
7.9.4 Maithili Life Sciences Main Business and Markets Served
7.9.5 Maithili Life Sciences Recent Developments/Updates
7.10 Hangzhou HETA Pharm & Chem
7.10.1 Hangzhou HETA Pharm & Chem Favipiravir API Company Information
7.10.2 Hangzhou HETA Pharm & Chem Favipiravir API Product Portfolio
7.10.3 Hangzhou HETA Pharm & Chem Favipiravir API Production, Value, Price, and Gross Margin (2021–2026)
7.10.4 Hangzhou HETA Pharm & Chem Main Business and Markets Served
7.10.5 Hangzhou HETA Pharm & Chem Recent Developments/Updates
7.11 Aurore Life Sciences
7.11.1 Aurore Life Sciences Favipiravir API Company Information
7.11.2 Aurore Life Sciences Favipiravir API Product Portfolio
7.11.3 Aurore Life Sciences Favipiravir API Production, Value, Price, and Gross Margin (2021–2026)
7.11.4 Aurore Life Sciences Main Business and Markets Served
7.11.5 Aurore Life Sciences Recent Developments/Updates
7.12 Bajaj Healthcare
7.12.1 Bajaj Healthcare Favipiravir API Company Information
7.12.2 Bajaj Healthcare Favipiravir API Product Portfolio
7.12.3 Bajaj Healthcare Favipiravir API Production, Value, Price, and Gross Margin (2021–2026)
7.12.4 Bajaj Healthcare Main Business and Markets Served
7.12.5 Bajaj Healthcare Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Favipiravir API Industry Chain Analysis
8.2 Favipiravir API Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Favipiravir API Production Modes and Processes
8.4 Favipiravir API Sales and Marketing
8.4.1 Favipiravir API Sales Channels
8.4.2 Favipiravir API Distributors
8.5 Favipiravir API Customer Analysis
9 Favipiravir API Market Dynamics
9.1 Favipiravir API Industry Trends
9.2 Favipiravir API Market Drivers
9.3 Favipiravir API Market Challenges
9.4 Favipiravir API Market Restraints
9.5 Impact of U.S. Tariffs
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
FEATURED COMPANIES
Chunghwa Chemical Synthesis & Biotech
Tagoor Laboratories
Biophore
Lee Pharma
Forewin Pharma
Senova Technology
Zhejiang Hengkang Pharmaceutical
Maithili Life Sciences
Hangzhou HETA Pharm & Chem
Aurore Life Sciences
Bajaj Healthcare
TODACO
List of Tables
 Table 1. Global Favipiravir API Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Favipiravir API Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Favipiravir API Production Capacity (Tons) by Manufacturers in 2025
 Table 4. Global Favipiravir API Production by Manufacturers (Tons), 2021–2026
 Table 5. Global Favipiravir API Production Market Share by Manufacturers (2021–2026)
 Table 6. Global Favipiravir API Production Value by Manufacturers (US$ Million), 2021–2026
 Table 7. Global Favipiravir API Production Value Share by Manufacturers (2021–2026)
 Table 8. Global Key Players of Favipiravir API, Industry Ranking, 2024 vs 2025
 Table 9. Classification of Companies by Tier (Tier 1, Tier 2, Tier 3), based on Favipiravir API Production Value, 2025
 Table 10. Global Market Favipiravir API Average Price by Manufacturers (US$/Ton), 2021–2026
 Table 11. Global Key Manufacturers of Favipiravir API, Manufacturing Footprints and Headquarters
 Table 12. Global Key Manufacturers of Favipiravir API, Product Offerings and Applications
 Table 13. Global Key Manufacturers of Favipiravir API, Date of Entry into the Industry
 Table 14. Global Favipiravir API Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 15. Mergers & Acquisitions and Expansion Plans
 Table 16. Global Favipiravir API Production Value by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 17. Global Favipiravir API Production Value (US$ Million) by Region (2021–2026)
 Table 18. Global Favipiravir API Production Value Market Share by Region (2021–2026)
 Table 19. Global Favipiravir API Production Value (US$ Million) Forecast by Region (2027–2032)
 Table 20. Global Favipiravir API Production Value Market Share Forecast by Region (2027–2032)
 Table 21. Global Favipiravir API Production Comparison by Region: 2021 vs 2025 vs 2032 (Tons)
 Table 22. Global Favipiravir API Production (Tons) by Region (2021–2026)
 Table 23. Global Favipiravir API Production Market Share by Region (2021–2026)
 Table 24. Global Favipiravir API Production (Tons) Forecast by Region (2027–2032)
 Table 25. Global Favipiravir API Production Market Share Forecast by Region (2027–2032)
 Table 26. Global Favipiravir API Market Average Price (US$/Ton) by Region (2021–2026)
 Table 27. Global Favipiravir API Market Average Price (US$/Ton) by Region (2027–2032)
 Table 28. Global Favipiravir API Consumption Growth Rate by Region: 2021 vs 2025 vs 2032 (Tons)
 Table 29. Global Favipiravir API Consumption by Region (Tons), 2021–2026
 Table 30. Global Favipiravir API Consumption Market Share by Region (2021–2026)
 Table 31. Global Favipiravir API Forecasted Consumption by Region (Tons), 2027–2032
 Table 32. Global Favipiravir API Forecasted Consumption Market Share by Region (2027–2032)
 Table 33. North America Favipiravir API Consumption Growth Rate by Country: 2021 vs 2025 vs 2032 (Tons)
 Table 34. North America Favipiravir API Consumption by Country (Tons), 2021–2026
 Table 35. North America Favipiravir API Consumption by Country (Tons), 2027–2032
 Table 36. Europe Favipiravir API Consumption Growth Rate by Country: 2021 vs 2025 vs 2032 (Tons)
 Table 37. Europe Favipiravir API Consumption by Country (Tons), 2021–2026
 Table 38. Europe Favipiravir API Consumption by Country (Tons), 2027–2032
 Table 39. Asia Pacific Favipiravir API Consumption Growth Rate by Region: 2021 vs 2025 vs 2032 (Tons)
 Table 40. Asia Pacific Favipiravir API Consumption by Region (Tons), 2021–2026
 Table 41. Asia Pacific Favipiravir API Consumption by Region (Tons), 2027–2032
 Table 42. Latin America, Middle East & Africa Favipiravir API Consumption Growth Rate by Country: 2021 vs 2025 vs 2032 (Tons)
 Table 43. Latin America, Middle East & Africa Favipiravir API Consumption by Country (Tons), 2021–2026
 Table 44. Latin America, Middle East & Africa Favipiravir API Consumption by Country (Tons), 2027–2032
 Table 45. Global Favipiravir API Production (Tons) by Type (2021–2026)
 Table 46. Global Favipiravir API Production (Tons) by Type (2027–2032)
 Table 47. Global Favipiravir API Production Market Share by Type (2021–2026)
 Table 48. Global Favipiravir API Production Market Share by Type (2027–2032)
 Table 49. Global Favipiravir API Production Value (US$ Million) by Type (2021–2026)
 Table 50. Global Favipiravir API Production Value (US$ Million) by Type (2027–2032)
 Table 51. Global Favipiravir API Production Value Market Share by Type (2021–2026)
 Table 52. Global Favipiravir API Production Value Market Share by Type (2027–2032)
 Table 53. Global Favipiravir API Price (US$/Ton) by Type (2021–2026)
 Table 54. Global Favipiravir API Price (US$/Ton) by Type (2027–2032)
 Table 55. Global Favipiravir API Production (Tons) by Application (2021–2026)
 Table 56. Global Favipiravir API Production (Tons) by Application (2027–2032)
 Table 57. Global Favipiravir API Production Market Share by Application (2021–2026)
 Table 58. Global Favipiravir API Production Market Share by Application (2027–2032)
 Table 59. Global Favipiravir API Production Value (US$ Million) by Application (2021–2026)
 Table 60. Global Favipiravir API Production Value (US$ Million) by Application (2027–2032)
 Table 61. Global Favipiravir API Production Value Market Share by Application (2021–2026)
 Table 62. Global Favipiravir API Production Value Market Share by Application (2027–2032)
 Table 63. Global Favipiravir API Price (US$/Ton) by Application (2021–2026)
 Table 64. Global Favipiravir API Price (US$/Ton) by Application (2027–2032)
 Table 65. Chunghwa Chemical Synthesis & Biotech Favipiravir API Company Information
 Table 66. Chunghwa Chemical Synthesis & Biotech Favipiravir API Specification and Application
 Table 67. Chunghwa Chemical Synthesis & Biotech Favipiravir API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
 Table 68. Chunghwa Chemical Synthesis & Biotech Main Business and Markets Served
 Table 69. Chunghwa Chemical Synthesis & Biotech Recent Developments/Updates
 Table 70. TODACO Favipiravir API Company Information
 Table 71. TODACO Favipiravir API Specification and Application
 Table 72. TODACO Favipiravir API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
 Table 73. TODACO Main Business and Markets Served
 Table 74. TODACO Recent Developments/Updates
 Table 75. Tagoor Laboratories Favipiravir API Company Information
 Table 76. Tagoor Laboratories Favipiravir API Specification and Application
 Table 77. Tagoor Laboratories Favipiravir API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
 Table 78. Tagoor Laboratories Main Business and Markets Served
 Table 79. Tagoor Laboratories Recent Developments/Updates
 Table 80. Biophore Favipiravir API Company Information
 Table 81. Biophore Favipiravir API Specification and Application
 Table 82. Biophore Favipiravir API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
 Table 83. Biophore Main Business and Markets Served
 Table 84. Biophore Recent Developments/Updates
 Table 85. Lee Pharma Favipiravir API Company Information
 Table 86. Lee Pharma Favipiravir API Specification and Application
 Table 87. Lee Pharma Favipiravir API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
 Table 88. Lee Pharma Main Business and Markets Served
 Table 89. Lee Pharma Recent Developments/Updates
 Table 90. Forewin Pharma Favipiravir API Company Information
 Table 91. Forewin Pharma Favipiravir API Specification and Application
 Table 92. Forewin Pharma Favipiravir API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
 Table 93. Forewin Pharma Main Business and Markets Served
 Table 94. Forewin Pharma Recent Developments/Updates
 Table 95. Senova Technology Favipiravir API Company Information
 Table 96. Senova Technology Favipiravir API Specification and Application
 Table 97. Senova Technology Favipiravir API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
 Table 98. Senova Technology Main Business and Markets Served
 Table 99. Senova Technology Recent Developments/Updates
 Table 100. Zhejiang Hengkang Pharmaceutical Favipiravir API Company Information
 Table 101. Zhejiang Hengkang Pharmaceutical Favipiravir API Specification and Application
 Table 102. Zhejiang Hengkang Pharmaceutical Favipiravir API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
 Table 103. Zhejiang Hengkang Pharmaceutical Main Business and Markets Served
 Table 104. Zhejiang Hengkang Pharmaceutical Recent Developments/Updates
 Table 105. Maithili Life Sciences Favipiravir API Company Information
 Table 106. Maithili Life Sciences Favipiravir API Specification and Application
 Table 107. Maithili Life Sciences Favipiravir API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
 Table 108. Maithili Life Sciences Main Business and Markets Served
 Table 109. Maithili Life Sciences Recent Developments/Updates
 Table 110. Hangzhou HETA Pharm & Chem Favipiravir API Company Information
 Table 111. Hangzhou HETA Pharm & Chem Favipiravir API Specification and Application
 Table 112. Hangzhou HETA Pharm & Chem Favipiravir API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
 Table 113. Hangzhou HETA Pharm & Chem Main Business and Markets Served
 Table 114. Hangzhou HETA Pharm & Chem Recent Developments/Updates
 Table 115. Aurore Life Sciences Favipiravir API Company Information
 Table 116. Aurore Life Sciences Favipiravir API Specification and Application
 Table 117. Aurore Life Sciences Favipiravir API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
 Table 118. Aurore Life Sciences Main Business and Markets Served
 Table 119. Aurore Life Sciences Recent Developments/Updates
 Table 120. Bajaj Healthcare Favipiravir API Company Information
 Table 121. Bajaj Healthcare Favipiravir API Specification and Application
 Table 122. Bajaj Healthcare Favipiravir API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
 Table 123. Bajaj Healthcare Main Business and Markets Served
 Table 124. Bajaj Healthcare Recent Developments/Updates
 Table 125. Key Raw Materials Lists
 Table 126. Raw Materials Key Suppliers Lists
 Table 127. Favipiravir API Distributors List
 Table 128. Favipiravir API Customers List
 Table 129. Favipiravir API Market Trends
 Table 130. Favipiravir API Market Drivers
 Table 131. Favipiravir API Market Challenges
 Table 132. Favipiravir API Market Restraints
 Table 133. Research Programs/Design for This Report
 Table 134. Key Data Information from Secondary Sources
 Table 135. Key Data Information from Primary Sources
 Table 136. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Favipiravir API
 Figure 2. Global Favipiravir API Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Favipiravir API Market Share by Type: 2025 vs 2032
 Figure 4. Purity ≥ 98% Product Picture
 Figure 5. Purity < 98% Product Picture
 Figure 6. Global Favipiravir API Market Value by Application (US$ Million), 2021–2032
 Figure 7. Global Favipiravir API Market Share by Application: 2025 vs 2032
 Figure 8. Pharmaceuticals
 Figure 9. Scientific Research
 Figure 10. Others
 Figure 11. Global Favipiravir API Production Value (US$ Million), 2021 vs 2025 vs 2032
 Figure 12. Global Favipiravir API Production Value (US$ Million), 2021–2032
 Figure 13. Global Favipiravir API Production Capacity (Tons), 2021–2032
 Figure 14. Global Favipiravir API Production (Tons), 2021–2032
 Figure 15. Global Favipiravir API Average Price (US$/Ton), 2021–2032
 Figure 16. Favipiravir API Report Years Considered
 Figure 17. Favipiravir API Production Share by Manufacturers in 2025
 Figure 18. Global Favipiravir API Production Value Share by Manufacturers (2025)
 Figure 19. Favipiravir API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 20. Top 5 and Top 10 Global Players: Market Share by Favipiravir API Revenue in 2025
 Figure 21. Global Favipiravir API Production Value by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Figure 22. Global Favipiravir API Production Value Market Share by Region: 2021 vs 2025 vs 2032
 Figure 23. Global Favipiravir API Production Comparison by Region: 2021 vs 2025 vs 2032 (Tons)
 Figure 24. Global Favipiravir API Production Market Share by Region: 2021 vs 2025 vs 2032
 Figure 25. North America Favipiravir API Production Value (US$ Million) Growth Rate (2021–2032)
 Figure 26. Europe Favipiravir API Production Value (US$ Million) Growth Rate (2021–2032)
 Figure 27. China Favipiravir API Production Value (US$ Million) Growth Rate (2021–2032)
 Figure 28. Japan Favipiravir API Production Value (US$ Million) Growth Rate (2021–2032)
 Figure 29. Global Favipiravir API Consumption by Region: 2021 vs 2025 vs 2032 (Tons)
 Figure 30. Global Favipiravir API Consumption Market Share by Region: 2021 vs 2025 vs 2032
 Figure 31. North America Favipiravir API Consumption and Growth Rate (Tons), 2021–2032
 Figure 32. North America Favipiravir API Consumption Market Share by Country (2021–2032)
 Figure 33. U.S. Favipiravir API Consumption and Growth Rate (Tons), 2021–2032
 Figure 34. Canada Favipiravir API Consumption and Growth Rate (Tons), 2021–2032
 Figure 35. Europe Favipiravir API Consumption and Growth Rate (Tons), 2021–2032
 Figure 36. Europe Favipiravir API Consumption Market Share by Country (2021–2032)
 Figure 37. Germany Favipiravir API Consumption and Growth Rate (Tons), 2021–2032
 Figure 38. France Favipiravir API Consumption and Growth Rate (Tons), 2021–2032
 Figure 39. U.K. Favipiravir API Consumption and Growth Rate (Tons), 2021–2032
 Figure 40. Italy Favipiravir API Consumption and Growth Rate (Tons), 2021–2032
 Figure 41. Russia Favipiravir API Consumption and Growth Rate (Tons), 2021–2032
 Figure 42. Asia Pacific Favipiravir API Consumption and Growth Rate (Tons), 2021–2032
 Figure 43. Asia Pacific Favipiravir API Consumption Market Share by Region (2021–2032)
 Figure 44. China Favipiravir API Consumption and Growth Rate (Tons), 2021–2032
 Figure 45. Japan Favipiravir API Consumption and Growth Rate (Tons), 2021–2032
 Figure 46. South Korea Favipiravir API Consumption and Growth Rate (Tons), 2021–2032
 Figure 47. China Taiwan Favipiravir API Consumption and Growth Rate (Tons), 2021–2032
 Figure 48. Southeast Asia Favipiravir API Consumption and Growth Rate (Tons), 2021–2032
 Figure 49. India Favipiravir API Consumption and Growth Rate (Tons), 2021–2032
 Figure 50. Latin America, Middle East & Africa Favipiravir API Consumption and Growth Rate (Tons), 2021–2032
 Figure 51. Latin America, Middle East & Africa Favipiravir API Consumption Market Share by Country (2021–2032)
 Figure 52. Mexico Favipiravir API Consumption and Growth Rate (Tons), 2021–2032
 Figure 53. Brazil Favipiravir API Consumption and Growth Rate (Tons), 2021–2032
 Figure 54. Turkey Favipiravir API Consumption and Growth Rate (Tons), 2021–2032
 Figure 55. GCC Countries Favipiravir API Consumption and Growth Rate (Tons), 2021–2032
 Figure 56. Global Production Market Share of Favipiravir API by Type (2021–2032)
 Figure 57. Global Production Value Market Share of Favipiravir API by Type (2021–2032)
 Figure 58. Global Favipiravir API Price (US$/Ton) by Type (2021–2032)
 Figure 59. Global Production Market Share of Favipiravir API by Application (2021–2032)
 Figure 60. Global Production Value Market Share of Favipiravir API by Application (2021–2032)
 Figure 61. Global Favipiravir API Price (US$/Ton) by Application (2021–2032)
 Figure 62. Favipiravir API Value Chain
 Figure 63. Channels of Distribution (Direct Vs Distribution)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions